fluoxetine has been researched along with mdl 100907 in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (40.00) | 29.6817 |
| 2010's | 15 (50.00) | 24.3611 |
| 2020's | 3 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatanaka, K; Yamaguchi, T; Yatsugi, S | 2 |
| Fantegrossi, WE; Godlewski, T; Karabenick, RL; Rice, KC; Stephens, JM; Ullrich, T; Woods, JH | 1 |
| Hietala, J; Majasuo, H; Pälvimäki, EP; Syvälahti, E | 1 |
| Abo, A; Artigas, F; Marek, GJ; Martin-Ruiz, R | 1 |
| Adnot, S; Benferhat, R; Eddahibi, S; Guignabert, C; Hamon, M; Raffestin, B; Raoul, W; Rideau, D; Zadigue, P | 1 |
| Homma, I; Kanamaru, M | 1 |
| Papakostas, GI; Shelton, RC | 1 |
| Cai, L; Hertz, L; Li, B; Nu, W; Peng, L; Zhang, H; Zhang, S | 1 |
| Amitani, H; Asakawa, A; Fujimiya, M; Fujitsuka, N; Hayashi, M; Inui, A; Kojima, S; Sameshima, M | 1 |
| Arai, Y; Chancellor, MB; de Groat, WC; Kaiho, Y; Kamo, I; Kitta, T; Miyazato, M; Sugaya, K; Yoshimura, N | 1 |
| Hertz, L; Li, B; Li, M; Peng, L; Zhang, S | 1 |
| Corral, RM; Gentil, V; Hale, A; Mencacci, C; Ruiz, JS; Severo, CA | 1 |
| David, DJ; Enhamre, E; Gabriel, C; Gardier, AM; Guilloux, JP; Hen, R; Mocaër, E; Rainer, Q; Xia, L | 1 |
| Iwamura, T; Kasai, M; Kato, S; Nisijima, K; Shioda, K; Yoshino, T | 1 |
| Pazos, A; Pilar-Cuéllar, F; Vidal, R | 1 |
| Vicente, MA; Zangrossi, H | 1 |
| Abman, SH; Delaney, C; Gien, J; Grover, TR; Roe, G | 1 |
| Howell, LL; Kimmel, HL; Murnane, KS; Rice, KC | 1 |
| Maraschin, M; Rodrigues, AL; Tasca, CI; Zeni, AL; Zomkowski, AD | 1 |
| Egashira, N; Fujiwara, M; Iwasaki, K; Mishima, K; Nagao, M; Oishi, R; Okuno, R; Shirakawa, A | 1 |
| Ali, AS; Ali, SA; Salim, S | 1 |
| Babapour, V; Baghbanzadeh, A; Hassanpour, S; Mokhtarpouriani, K; Pourrahimi, M; Zendehdel, M | 1 |
| Corbach-Söhle, S; Flügge, G; Fuchs, E; Kohlhause, S; Schlumbohm, C; Schmelting, B | 1 |
| Aissouni, Y; Chalus, M; Courteix, C; Dupuis, A; Eschalier, A; Hernández, A; Marin, P; Pelissier, T; Pichon, X; Privat, AM; Wattiez, AS | 1 |
| Chachra, P; Sarkar, A; Vaidya, VA | 1 |
| Corrêa, FM; Joca, SR; Resstel, LB; Scopinho, AA; Stanquini, LA | 1 |
| Cha, E; Kim, HJ; Kim, J; Lee, HY; Lim, SM; Pae, AN; Park, WK | 1 |
| Carratala-Ros, C; Correa, M; Desai, PA; Ferrigno, SM; Hurley, EM; Kuperwasser, FB; McMullen, HP; Murphy, CE; Presby, RE; Rotolo, RA; Salamone, JD; Zorda, EM | 1 |
| Boyko, A; Kudrin, V; Melnikov, M; Pashenkov, M; Rogovskii, V; Sviridova, A | 1 |
1 review(s) available for fluoxetine and mdl 100907
| Article | Year |
|---|---|
Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Drug Resistance; Drug Therapy, Combination; Fluoxetine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Serotonin 5-HT2 Receptor Antagonists; Thiazoles; Trazodone; Triazoles | 2008 |
1 trial(s) available for fluoxetine and mdl 100907
| Article | Year |
|---|---|
Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study.
Topics: Acetamides; Adolescent; Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Fluoxetine; Humans; Internationality; Male; Middle Aged; Patient Dropouts; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Severity of Illness Index; Young Adult | 2010 |
28 other study(ies) available for fluoxetine and mdl 100907
| Article | Year |
|---|---|
Effect of acute treatment with YM992 on extracellular serotonin levels in the rat frontal cortex.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Cerebral Cortex; Citalopram; Cyclohexanols; Dose-Response Relationship, Drug; Extracellular Space; Fluorobenzenes; Fluoxetine; Frontal Lobe; Male; Morpholines; p-Chloroamphetamine; Piperidines; Rats; Rats, Wistar; Serotonin; Serotonin Agents; Serotonin Antagonists; Synaptosomes; Tritium; Venlafaxine Hydrochloride | 2000 |
Effect of acute treatment with YM992 on extracellular norepinephrine levels in the rat frontal cortex.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Citalopram; Cyclohexanols; Dose-Response Relationship, Drug; Extracellular Space; Fluorobenzenes; Fluoxetine; Frontal Lobe; Male; Morpholines; Norepinephrine; Piperidines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Venlafaxine Hydrochloride | 2000 |
Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.
Topics: Animals; Body Temperature; Cold Temperature; Crowding; Dose-Response Relationship, Drug; Fluorobenzenes; Fluoxetine; Hallucinogens; Ketanserin; Lethal Dose 50; Male; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Platelet Aggregation Inhibitors; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Social Isolation; Stereoisomerism; Telemetry | 2003 |
Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments.
Topics: Amphetamines; Animals; Choroid Plexus; Citalopram; Dose-Response Relationship, Drug; Ergolines; Fluoxetine; Hydrolysis; Inositol Phosphates; Male; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Second Messenger Systems; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2005 |
The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain Chemistry; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Synergism; Extracellular Space; Fluorobenzenes; Fluoxetine; Male; Microdialysis; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Reinforcement Schedule; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2005 |
Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats.
Topics: Animals; Cell Proliferation; Fluoxetine; Hypertension, Pulmonary; Lung; Monocrotaline; Muscle, Smooth, Vascular; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Up-Regulation | 2005 |
Compensatory airway dilation and additive ventilatory augmentation mediated by dorsomedial medullary 5-hydroxytryptamine 2 receptor activity and hypercapnia.
Topics: Airway Resistance; Animals; Carbon Dioxide; Ergolines; Fluoxetine; Hypercapnia; Hypoglossal Nerve; Male; Mice; Mice, Inbred C57BL; Receptors, Serotonin, 5-HT2; Respiratory Mechanics; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Solitary Nucleus | 2007 |
Fluoxetine-mediated 5-HT2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation.
Topics: Aminopyridines; Animals; Antidepressive Agents, Second-Generation; Astrocytes; Butadienes; Calcium; Cells, Cultured; Chelating Agents; Dipeptides; Dose-Response Relationship, Drug; Egtazic Acid; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Fluorobenzenes; Fluoxetine; Gene Expression; Indoles; Maleimides; Mice; Nitriles; Phosphorylation; Piperidines; Protein Kinase C; Proto-Oncogene Proteins c-fos; Quinazolines; Receptor, Serotonin, 5-HT2B; RNA, Messenger; Signal Transduction; Substrate Specificity; Transcriptional Activation; Tyrphostins; Up-Regulation; Urea | 2008 |
Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin.
Topics: Animals; Drugs, Chinese Herbal; Eating; Fenfluramine; Fluoxetine; Fluvoxamine; Gastrointestinal Motility; Ghrelin; Growth Hormone; Injections, Intraventricular; Male; Oligopeptides; Paroxetine; Piperazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Receptors, Ghrelin; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2009 |
Role of spinal serotonergic pathways in sneeze-induced urethral continence reflex in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Female; Fluoxetine; Piperazines; Pressure; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT2; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Sneezing; Spiro Compounds; Sulfonamides; Urethra; Urinary Incontinence, Stress | 2009 |
Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation.
Topics: Animals; Astrocytes; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluoxetine; Gene Expression Regulation; Indoles; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phospholipases A2; Phosphorylation; Receptor, Serotonin, 5-HT2B; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Time Factors; Urea | 2009 |
Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety.
Topics: Acetamides; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Cell Proliferation; Circadian Rhythm; Corticosterone; Dendrites; Depressive Disorder; Disease Models, Animal; Fluoxetine; Hippocampus; Male; Mice, Inbred C57BL; Motor Activity; Neurogenesis; Neurons; Serotonin 5-HT2 Receptor Antagonists | 2012 |
The effects of mirtazapine and fluoxetine on hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Disease Models, Animal; Fever; Fluoxetine; Male; Mianserin; Mirtazapine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Serotonin 5-HT2 Receptor Antagonists; Serotonin Agents | 2011 |
Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; beta Catenin; Brain-Derived Neurotrophic Factor; Fluoxetine; Hippocampus; Ketanserin; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Swimming | 2012 |
Serotonin-2C receptors in the basolateral nucleus of the amygdala mediate the anxiogenic effect of acute imipramine and fluoxetine administration.
Topics: Aminopyridines; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Avoidance Learning; Basolateral Nuclear Complex; Exploratory Behavior; Fluoxetine; Imipramine; Indoles; Male; Maze Learning; Neuropsychological Tests; Pyrazines; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2012 |
Pulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetus.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Dose-Response Relationship, Drug; Female; Fetus; Fluoxetine; Hemodynamics; Hypertension, Pulmonary; Hysterotomy; Indoles; Ketanserin; Lung; Oxadiazoles; Piperazines; Pregnancy; Pulmonary Artery; Pyridines; Receptors, Serotonin; rho-Associated Kinases; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Sertraline; Sheep; Vascular Resistance | 2011 |
The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): a concurrent microdialysis and plasma analysis study.
Topics: Animals; Female; Fluorobenzenes; Fluoxetine; Hallucinogens; Macaca mulatta; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Prolactin; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Antagonists; Stereoisomerism; Time Factors | 2012 |
Ferulic acid exerts antidepressant-like effect in the tail suspension test in mice: evidence for the involvement of the serotonergic system.
Topics: Animals; Antidepressive Agents; Coumaric Acids; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Immobility Response, Tonic; Ketanserin; Male; Mice; Motor Activity; Paroxetine; Piperazines; Pyridines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Sertraline | 2012 |
Role of 5-hydroxytryptamine2C receptors in marble-burying behavior in mice.
Topics: Aminopyridines; Amphetamines; Animals; Behavior, Animal; Fluoxetine; Indoles; Male; Mice; Mice, Inbred ICR; Motor Activity; Obsessive-Compulsive Disorder; Paroxetine; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2012 |
5-HT receptor subtypes as key targets in mediating pigment dispersion within melanophores of teleost, Oreochromis mossambicus.
Topics: Allylbenzene Derivatives; Animals; Benzyl Compounds; Dioxolanes; Dose-Response Relationship, Drug; Fish Proteins; Fluoxetine; Melanins; Melanophores; Metergoline; Pigments, Biological; Pyrogallol; Receptors, Serotonin; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Sumatriptan; Tilapia; Trazodone; Yohimbine | 2013 |
The effect of serotonergic system on nociceptin/orphanin FQ induced food intake in chicken.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aminopyridines; Animals; Chickens; Feeding Behavior; Fenclonine; Fluoxetine; Indoles; Injections, Intraventricular; Male; Nociceptin; Opioid Peptides; Receptor, Serotonin, 5-HT2C; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2013 |
Agomelatine in the tree shrew model of depression: effects on stress-induced nocturnal hyperthermia and hormonal status.
Topics: Acetamides; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Body Temperature; Body Weight; Central Nervous System Depressants; Circadian Rhythm; Depressive Disorder; Fever; Fluoxetine; Hydrocortisone; Indoles; Male; Melatonin; Motor Activity; Norepinephrine; Pyridines; Serotonin 5-HT2 Receptor Antagonists; Stress, Psychological; Tupaiidae | 2014 |
Disruption of 5-HT2A receptor-PDZ protein interactions alleviates mechanical hypersensitivity in carrageenan-induced inflammation in rats.
Topics: Animals; Bicuculline; Carrageenan; Disks Large Homolog 4 Protein; Fluorobenzenes; Fluoxetine; Hyperalgesia; Inflammation; Injections; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Pain; Peptides; Piperidines; Posterior Horn Cells; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists | 2013 |
Postnatal fluoxetine-evoked anxiety is prevented by concomitant 5-HT2A/C receptor blockade and mimicked by postnatal 5-HT2A/C receptor stimulation.
Topics: Animals; Anxiety; Depression; Fluoxetine; Gene Expression; Male; Motor Activity; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2014 |
Prelimbic cortex 5-HT1A and 5-HT2C receptors are involved in the hypophagic effects caused by fluoxetine in fasted rats.
Topics: Aminopyridines; Animals; Benzamides; Dose-Response Relationship, Drug; Eating; Fasting; Fluoxetine; Indoles; Male; Microinjections; Motor Activity; Oxadiazoles; Piperazines; Prefrontal Cortex; Pyridines; Rats; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists | 2015 |
Evaluation of anti-depressant effects of phthalazinone-based triple-acting small molecules against 5-HT
Topics: Animals; Antidepressive Agents; Azoles; Behavior, Animal; Drug Design; Fluoxetine; Humans; Inhibitory Concentration 50; Mice; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship | 2020 |
Sex differences in lever pressing and running wheel tasks of effort-based choice behavior in rats: Suppression of high effort activity by the serotonin transport inhibitor fluoxetine.
Topics: Animals; Antidepressive Agents; Choice Behavior; Feeding Behavior; Female; Fluoxetine; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Sex Factors | 2021 |
The role of 5-HT
Topics: Adult; Female; Fluoxetine; Humans; Male; Multiple Sclerosis; Receptor, Serotonin, 5-HT2B; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Th1 Cells; Th17 Cells; Young Adult | 2021 |